Custom Synthesis

Introduction: Peptide-Oligonucleotide Conjugates in Gene Silencing applications have emerged as one of the most technically sophisticated and clinically promising strategies […]

Introduction Antisense Oligonucleotide-Peptide Conjugates have emerged as an advanced therapeutic platform designed to address the longstanding pharmacokinetic, biodistribution, and intracellular

Introduction Cell-Penetrating Peptides in Oligonucleotide Conjugates are sophisticated chimeric macromolecules developed to address the significant challenge of poor cellular uptake

Introduction Peptide-oligonucleotide conjugates (POCs) demand tightly controlled chemical, thermal, and physical conditions to preserve their structural integrity and biological functionality

Introduction: The immunogenicity of peptide-oligonucleotide conjugates is one of the most consequential development risks facing sponsors working with this rapidly

Introduction to Peptide-Oligonucleotide Conjugates Specification Setting Peptide-Oligonucleotide Conjugates Specification Setting is the systematic process of establishing scientifically justified physical, chemical,

Introduction: A receptor-targeted peptide oligonucleotide conjugate (POC) is an engineered biotherapeutic that links an antisense oligonucleotide (ASO) payload to a

Introduction to Regulatory Expectations for Peptide-Oligonucleotide Conjugates in IND Submissions The regulatory pathway for advancing Peptide-Oligonucleotide Conjugates (POCs) in Investigational

Introduction The successful clinical development and regulatory approval of hybrid biotherapeutics depend on advanced analytical strategies for the Structural Characterization

The development and clinical advancement of hybrid biotherapeutics relies heavily on specialized HPLC Purification Services for Peptide-Oligonucleotide Conjugates that can